EDGAR Filing Documents for 0001485003-17-000097

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

SEC Accession No. 0001485003-17-000097

Filing Date

2017-10-17

Accepted

2017-10-16 21:56:18

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-1/A	ebioforms-1a12017xshortform.htm	S-1/A	509895
2	EXHIBIT 1.1	ebio-underwritingagreement.htm	EX-1.1	194130
3	EXHIBIT 5.1	ex51opinionhogan.htm	EX-5.1	10267
4	EXHIBIT 23.1	ex231consentofey.htm	EX-23.1	2399
5	EXHIBIT 23.2	ex232consentofpwc.htm	EX-23.2	2907
6		ebiologoa30.jpg	GRAPHIC	89522
7		ebiologoa31.jpg	GRAPHIC	3986
8		hllogoa02.jpg	GRAPHIC	28096
	Complete submission text file	0001485003-17-000097.txt		888010

Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142

Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550

Eleven Biotherapeutics, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-220809 | Film No.: 171139742
SIC: 2834 Pharmaceutical Preparations